Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (Q53245769)
Jump to navigation
Jump to search
scientific article published on 16 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. |
scientific article published on 16 September 2015 |
Statements
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (English)
Gilles Montalescot
1 reference
A Michael Lincoff
1 reference
Steven E Nissen
Stephen J Nicholls
Philip J Barter
H Bryan Brewer
Keith A A Fox
C Michael Gibson
Christopher Grainger
Venugopal Menon
Daniel Rader
Alan R Tall
Ellen McErlean
Jeffrey Riesmeyer
Burkhard Vangerow
Giacomo Ruotolo
Govinda J Weerakkody
16 September 2015
170
6
1061-1069